-
1 Comment
ECS Botanics Holdings Ltd is currently in a long term downtrend where the price is trading 12.8% below its 200 day moving average.
From a valuation standpoint, the stock is 64.0% cheaper than other stocks from the Technology sector with a price to sales ratio of 25.7.
ECS Botanics Holdings Ltd's total revenue rose by 130.3% to $587K since the same quarter in the previous year.
Its net income has increased by 22.6% to $-3M since the same quarter in the previous year.
Finally, its free cash flow grew by 46.7% to $-1M since the same quarter in the previous year.
Based on the above factors, ECS Botanics Holdings Ltd gets an overall score of 4/5.
ISIN | AU0000052490 |
---|---|
Exchange | AU |
CurrencyCode | AUD |
Sector | Healthcare |
Industry | Drug Manufacturers - Specialty & Generic |
Market Cap | 14M |
---|---|
PE Ratio | None |
Target Price | None |
Beta | 0.88 |
Dividend Yield | None |
ECS Botanics Holdings Ltd engages in the cultivation, manufacture, and sale of medicinal cannabis products in Northwest Victoria. The company is involved in the agriculture business. ECS Botanics Holdings Ltd is based in Murrabit, Australia.
Learn MoreHere's how to backtest a trading strategy or backtest a portfolio for ECS.AU using our backtest tool. PyInvesting provides the backtesting software for you to backtest your investment strategy. Our backtest software is written using Python code and allows you to backtest stock, backtest etf, backtest options, backtest crypto and backtest forex online. Our backtesting Python framework is highly robust and gives you a realistic simulation of how your strategy would have performed in the past using backtest data.
© PyInvesting 2025